TREATMENT OF VIOLATIONS ASSOCIATED WITH THE MECP2 GENE

摘要

The invention relates to the use of cystamine, cysteamine or a salt thereof, or calcineurin inhibitors for the treatment of a disorder associated with MeCP2, for example, Rett syndrome.